| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |